Manuscripts
Showing 1543 manuscripts.
Lack of increased hepatotoxicity in HIV-infected pregnant women receiving nevirapine compared with other antiretrovirals
Citation
Ming Lu, David E Shapiro, Ronald C Hershow, Audrey L French, Robert M Leighty, Bruce Thompson, Ruth E Tuomala, David W Ouyang, Susan Brogly. Lack of increased hepatotoxicity in HIV-infected pregnant women receiving nevirapine compared with other antiretrovirals. AIDS. 2010. 24: 109-14. PMID: 19926957Year
2010
Journal
AIDS
Study
P1025
Prenatal protease inhibitor use and risk of preterm birth among HIV-infected women initiating antiretroviral drugs during pregnancy
Citation
Susan B Brogly, Elizabeth G Livingston, Alice M Stek, Arlene D Bardeguez, Ruth E Tuomala, Kunjal Patel, David E Shapiro. Prenatal protease inhibitor use and risk of preterm birth among HIV-infected women initiating antiretroviral drugs during pregnancy. Journal of Infectious Diseases. 2010. 201: 1035-44. PMID: 20196654Year
2010
Journal
Journal of Infectious Diseases
Study
P1025
Total body and spinal bone mineral density across Tanner stage in perinatally HIV-infected and uninfected children and youth in PACTG 1045
Citation
Denise Jacobson, Jane C. Lindsey, Catherine M. Gordon, John ( Jack ) Moye, Dana S. Hardin, Kathleen Mulligan, Grace M. Aldrovandi. Total body and spinal bone mineral density across Tanner stage in perinatally HIV-infected and uninfected children and youth in PACTG 1045. AIDS. 2010. 24: 687-96. PMID: 20168204Year
2010
Journal
AIDS
Study
P1045
Birth defects among children born to human immunodeficiency virus-infected women: pediatric AIDS clinical trials protocols 219 and 219C.
Citation
Susan Brogly, Mark J. Abzug, Heather D. Watts, Coleen K. Cunningham, Paige L. Williams, James M. Oleske, Daniel H. Conway, Rhoda S. Sperling, Hans ML Spiegel, Russell B. Van Dyke. Birth defects among children born to human immunodeficiency virus-infected women: pediatric AIDS clinical trials protocols 219 and 219C.. Pediaric Infectious Disease Journal. 2010. 29: 721-727. PMID: 20539252Year
2010
Journal
Pediaric Infectious Disease Journal
Impaired Generation of Hepatitis B Virus-specific Memory B Cells in HIV Infected Individuals Following Vaccination
Citation
Nishaki Mehta, Coleen K. Cunningham, Patricia M. Flynn, Joyce Pepe, Stephen Obaro, Bill G. Kapogiannis, James Bethel, Katherine Luzuriaga. Impaired Generation of Hepatitis B Virus-specific Memory B Cells in HIV Infected Individuals Following Vaccination. Vaccine. 2010. 28: 3672-8. PMID: 20356567Year
2010
Journal
Vaccine
Co-Occuring Psychiatric Symptoms in Children Perinatally Infected With HIV and Peer Comparison Sample.
Citation
Kenneth D. Gadow, Miriam Chernoff, Paige L. Williams, Pim Brouwers, Jerry D. Heston, Edward V. Morse, Janice Hodge, Vinnie Dipoalo, Nagamah Sandra Deygoo, Sharon Appelbaum Nachman. Co-Occuring Psychiatric Symptoms in Children Perinatally Infected With HIV and Peer Comparison Sample.. Journal Of Developmental and Behavioral Pediatrics. 2010. 31: 116-128. PMID: 20110828Year
2010
Journal
Journal Of Developmental and Behavioral Pediatrics
Study
P1055
Low frequency NNRTI-resistant variants contribute to failure of efavirenz-containing regimens in treatment-experienced patients
Citation
Elias (Lou) K. Halvas, A. Wiegand, Valerie F. Boltz, Mary Kearney, Dwight V. Nissley, Michael Wantman, Scott M. Hammer, Sarah Palmer, Florin Vaida, John Coffin, John W. Mellors. Low frequency NNRTI-resistant variants contribute to failure of efavirenz-containing regimens in treatment-experienced patients. Journal of Infectious Diseases. 2010. 201: 672-80. PMID: 20102272Year
2010
Journal
Journal of Infectious Diseases
A pilot study to determine the impact on dyslipidemia of adding tenofovir to stable background antiretroviral therapy: ACTG 5206
Citation
Marisa T. Tungsiripat, Doug Kitch, Marshall Jay Glesby, Samir K. Gupta, John W. Mellors, Laura E. Moran, Lynne Jones, Beverly L. Alston-Smith, James F. Rooney, Judith A. Aberg. A pilot study to determine the impact on dyslipidemia of adding tenofovir to stable background antiretroviral therapy: ACTG 5206. AIDS. 2010. 24: 1781-4. PMID: 20495438Year
2010
Journal
AIDS
Treatment with pravastatin and fenofibrate improves atherogenic lipid profiles but not inflammatory markers in ACTG 5087
Citation
Carl J. Fichtenbaum, Tzu-min Yeh, Scott Evans, Judith A. Aberg. Treatment with pravastatin and fenofibrate improves atherogenic lipid profiles but not inflammatory markers in ACTG 5087. Journal of Clinical Lipidology. 2010. 4: 279-87. PMID: 20824151Year
2010
Journal
Journal of Clinical Lipidology
Measurement of antiretroviral drugs in the lungs of HIV-infected patients
Citation
Homer L. Twigg, Carol T Schnizlein Bick, Michael D. Weiden, Fred T. Valentine, L. Joseph Wheat, Richard B. Day, Helen C. Rominger-Grubbs, Lu (Summer) Zheng, Ronald G. Collman, Robert W. Coombs, R. Pat Bucy, Naser L. Rezk, Angela D.M. Kashuba. Measurement of antiretroviral drugs in the lungs of HIV-infected patients. HIV Therapy. 2010. 4: 247-51. PMID: 20436781Year
2010
Journal
HIV Therapy